Edit
MiroBio Ltd
http://www.mirobio.com/Last activity: 04.08.2022
Probably Closed - Reference to Gilead Sciences
Our mission at MiroBio is to deliver transformational immunotherapies for people suffering from autoimmune disease. Immune imbalance is at the heart of many conditions which are marked by an attack on the body’s own cells. MiroBio is advancing a new class of therapies designed to restore immune balance – or homeostasis – and potentially provide durable remission from these chronic, complex conditions.
To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research.
MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.
To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research.
MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.
Location: United Kingdom, England, Oxford
Employees: 11-50
Total raised: $97.03M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| 18.07.2022 | OrbiMed | orbimed.co... |
| - | Oxford Sci... | oxfordscie... |
| - | Advent Lif... | adventls.c... |
| 26.09.2021 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.06.2022 | Series B | $97.03M | Medicxi |
Mentions in press and media 4
| Date | Title | Description |
| 04.08.2022 | Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M | U.S. pharmaceutical giant Gilead Sciences has announced plans to acquire Oxford University biotech spinout company MiroBio in an all-cash deal worth $405 million. MiroBio is a clinical-stage company focused on developing treatments to “rest... |
| 29.06.2022 | MiroBio Raises $97 Million Series B Financing to Develop Checkpoint Agonists for Treatment of Autoimmune Diseases | - |
| 29.06.2022 | MiroBio Raises $97 Million Series B Financing to Develop Checkpoint Agonists for Treatment of Autoimmune Diseases | MiroBio Raises $97 Million Series B Financing to Develop Checkpoint Agonists for Treatment of Autoimmune Diseases Financing led by Medicxi with significant participation from new and existing shareholdersLead program MB272 targeting checkpo... |
| 07.01.2021 | Biggest winners, brightest futures: 10 young tech startups from UK ready to own 2021 | Want to know which newly-founded tech startup from UK gained maximum popularity in 2020? Or raised the maximum funding? Which one has the most eminent future? Many startups that stepped into the gap of legacy companies have been scaleups: f... |